Jinling Pharmaceutical Co Ltd
SZSE:000919
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Jinling Pharmaceutical Co Ltd
Long-Term Investments
Jinling Pharmaceutical Co Ltd
Long-Term Investments Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Long-Term Investments | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
J
|
Jinling Pharmaceutical Co Ltd
SZSE:000919
|
Long-Term Investments
¥218.9m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
6%
|
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Long-Term Investments
¥772.5m
|
CAGR 3-Years
6%
|
CAGR 5-Years
94%
|
CAGR 10-Years
N/A
|
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Long-Term Investments
¥2B
|
CAGR 3-Years
10%
|
CAGR 5-Years
6%
|
CAGR 10-Years
40%
|
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Long-Term Investments
¥13.6B
|
CAGR 3-Years
4%
|
CAGR 5-Years
56%
|
CAGR 10-Years
58%
|
|
|
Zhejiang Nhu Co Ltd
SZSE:002001
|
Long-Term Investments
¥1.4B
|
CAGR 3-Years
47%
|
CAGR 5-Years
31%
|
CAGR 10-Years
32%
|
|
|
S
|
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
|
Long-Term Investments
¥1.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
N/A
|
|
Jinling Pharmaceutical Co Ltd
Glance View
Jinling Pharmaceutical Co. Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Nanjing, Jiangsu and currently employs 4,865 full-time employees. The Company’s main products include Mailuoning injections, ferrous succinate tablets and Lentinan injection, among others. The firm is also involved in the provision of medical services and the sale of medical instrument. The firm distributes its products in domestic market, with North China as its main market.
See Also
What is Jinling Pharmaceutical Co Ltd's Long-Term Investments?
Long-Term Investments
218.9m
CNY
Based on the financial report for Dec 31, 2025, Jinling Pharmaceutical Co Ltd's Long-Term Investments amounts to 218.9m CNY.
What is Jinling Pharmaceutical Co Ltd's Long-Term Investments growth rate?
Long-Term Investments CAGR 10Y
6%
Over the last year, the Long-Term Investments growth was -50%. The average annual Long-Term Investments growth rates for Jinling Pharmaceutical Co Ltd have been -7% over the past three years , -13% over the past five years , and 6% over the past ten years .
